Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIn the UK, private Wegovy prescriptions are typically priced by dose, with monthly costs generally ranging from around £149 to £375 depending on the strength and the provider — figures that shifted noticeably after Eli Lilly's list-price increase in September 2025 also moved market expectations across injectable weight-loss medicines. Wegovy (semaglutide) is a prescription-only medicine for weight management, meaning no private provider can supply it without a clinical assessment; a prescriber decides suitability, not a checkout page. What you pay for, legitimately, is that clinical layer alongside the medicine itself.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
NICE recommended semaglutide for weight management in its technology appraisal TA875, and the clinical trial that underpinned approval (STEP 1, published in the New England Journal of Medicine) reported around 15% average body-weight reduction at the 2.4mg maintenance dose over 68 weeks. That evidence base is part of why demand pushed private prices upward, and why the market is now more expensive than it was two years ago.
Treatment starts at 0.25mg and is titrated by a prescriber through 0.5mg, 1.0mg and 1.7mg toward the 2.4mg maintenance dose, each step roughly four weeks apart. Pricing almost always reflects the dose pen you actually need at each stage, so how much 1mg Wegovy costs differs from the cost at 2.4mg, and a provider quoting a low entry figure may be quoting the lowest starting-dose pen only. By the time most patients reach maintenance, they are paying the higher end of the range.
The MHRA also approved a 7.2mg single-dose pen in April 2026, the highest Wegovy dose available, trials reported around 20.7% average weight loss at this level. Availability and pricing for this format vary by clinic; specifics are confirmed at consultation.
A private prescription for Wegovy involves more than the pen. Yet advertised prices frequently strip out the consultation fee, the prescription charge, delivery costs and any ongoing clinical support. Add those separately and the actual monthly outlay can be meaningfully higher than the figure in the advert.
Some providers charge per consultation for every dose change. Others add a separate prescription fee on top of the medicine price. Delivery may be standard rather than tracked, or charged at a flat rate per order. Aftercare (someone to contact if side effects are difficult, or if you need a clinical decision about pausing treatment) is sometimes a premium add-on rather than standard practice.
The cost of a Wegovy pen is only one part of the picture. Understanding what the full monthly cost looks like, including everything needed to use treatment safely, is a better basis for comparison than the lowest figure on a comparison table.
One transparent price covers the consultation, prescription, treatment, next-working-day tracked DPD delivery and aftercare seven days a week. Nothing is billed separately. There are no subscriptions and no auto-renewals; every repeat order goes back through clinical review before anything is dispatched.
We are deliberately not the cheapest option on the market. The single price exists because splitting things out creates surprises later, and surprises around a prescription medicine are not the kind patients should have. Our prescribers are GPhC-registered Independent Prescribers (real clinicians, not software) who review consultations personally. Specific treatment pricing is shown on our weight-loss treatments page.
There are no discount codes, voucher schemes or promotional pricing at nume. If you see a code offering a percentage off injectable weight-loss medicines from an unfamiliar seller, that is a red flag rather than a saving, see below.
The MHRA has documented counterfeit Wegovy, Ozempic and tirzepatide pens circulating in the UK, including fake pens containing insulin rather than the stated medicine. Some hospitalisations have resulted. Enforcement operations in 2025 resulted in seizures of roughly 20 million doses of illegally traded weight-loss medicines worth around £45 million. The pattern is consistent: very low prices, sellers operating outside the licensed supply chain, and no genuine prescriber involved.
For a prescription-only medicine, the right questions are about the clinical process and the supply chain, not the price tag. You can verify any online pharmacy on the GPhC register before ordering; nume's registration number is 9012878. Suspect sellers can be reported directly through the MHRA's Yellow Card scheme. That step takes two minutes and can protect the next person.
For more on Wegovy more broadly (how it works, who it suits, and the full evidence picture) our Wegovy overview covers it. Questions about a specific dose's costs are answered on our Wegovy price page. And if you want to talk through suitability with a prescriber, start your free consultation and a clinician will review it the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.